Programmed death ligand 1 (PD-L1) expression influences the immune-tolerogenic microenvironment in antiretroviral therapy-refractory Kaposi's sarcoma: A pilot study

Upregulation of programmed death ligand 1 (PD-L1) is a mechanism of immune escape utilized by a variety of tumors. PD-L1 expression in tumor cells or in the surrounding infiltrate correlates with clinical responsiveness to novel therapies targeting the PD-1/PD-L1 immune checkpoint. In the context of...

Full description

Saved in:
Bibliographic Details
Published in:Oncoimmunology
Main Authors: Mletzko, Salvinia, Pinato, David J., Robey, Rebecca C., Dalla Pria, Alessia, Benson, Peter, Imami, Nesrina, Bower, Mark
Format: Artigo
Language:Inglês
Published: Taylor & Francis 2017
Subjects:
Brief Report
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5593697/
https://ncbi.nlm.nih.gov/pubmed/28919987
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2017.1304337
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items